At the heart of #ThinkingPatientAffairs beats a simple principle: the patient is not just a number.
In an era where medicine aims to be personalized, sustainable and patient-centered, Real World Evidence (RWE) emerges as a crucial tool.
It’s not theory, but practice. Not prediction, but observation. It answers the question: does it really work?
Today, RWE is a cornerstone of modern medicine, because it tells the story of what actually happens in the real world, where people live, work, manage multiple conditions, and have to balance treatment with everyday life.
Concrete insights that highlight the real patient experience. We often discuss this as Thinking Patient Affairs, a space where we imagine healthcare innovation through the eyes of those who live it.
Because data are not just numbers: they are stories, choices, lived experiences.
True innovation is thinking of RWE as a complement to experimental medicine. From the laboratory to the concreteness of the wards, where every therapy is a human experience. A bridge between research and everyday life.
But to achieve RWE, a pact is needed: the patient must be an active part.
Not just a source of data, but an aware protagonist. Involving patients in data collection and sharing means ensuring transparency, protecting privacy, and providing the tools to take part in decision-making.
It’s a call to action coming loud and clear from patient organizations, now true stakeholder of change.
The Patient complexity becomes part of the solution
Of course, challenges remain: data quality, risk of bias and the need for clear governance. But the potential is enormous—a medicine more responsive, more equitable.
RWE marks a scientific evolution that goes hand in hand with a cultural transformation: seeing care not only through the lens of protocols, but through the eyes of those who live it every day.
Patient engagement is not optional, it is essential.
A genuine partnership in building a healthcare system that considers the complexity of real life, not just academic evidence.
A fairer, truer medicine
It is a matter of equity: listening to everyone, not just “trial patients”, recognizing that a drug must work first at home, then in clinical trials.
Because care is not just a molecule, it’s relationship, context, experience. Perhaps this is exactly where a more human medicine can begin again.
A medicine that does not ask the patient to fit the model, but adapts the model to the patient’s world.
Talking about Patient Affairs means understanding where science meets real life.